No Data
BofA Securities Maintains Envista Holdings(NVST.US) With Buy Rating, Maintains Target Price $22
BofA Securities analyst Allen Lutz maintains $Envista Holdings(NVST.US)$ with a buy rating, and maintains the target price at $22.According to TipRanks data, the analyst has a success rate of 48.2%
A Quick Look at Today's Ratings for Envista Holdings(NVST.US), With a Forecast Between $18 to $22
On Jul 16, major Wall Street analysts update their ratings for $Envista Holdings(NVST.US)$, with price targets ranging from $18 to $22.BofA Securities analyst Allen Lutz maintains with a buy rating,
Analysts' Top Healthcare Picks: Accolade (ACCD), Envista Holdings (NVST)
Analysts Offer Insights on Healthcare Companies: Envista Holdings (NVST) and Select Medical (SEM)
Expert Outlook: Envista Holdings Through The Eyes Of 5 Analysts
Envista Holdings (NYSE:NVST) has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.The following table provides a quick overview
Express News | Needham Reiterates Hold on Envista Holdings